Procept Biorobotics Corp (PRCT NASDAQ) stock market data APIs
$24.1304
-0.31(-1.3%)
as of March 6, 2026
Try our APIs with
free plan!
Procept Biorobotics Corp Financial Data Overview
Price chart is built with
Anychart
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Prev. Close
24.1304
Open
23.8205
High
24.7361
Low
22.675
52 wk Range
19.35-66.85
Market Cap
1 366 M
Shares Outstanding
56 390 K
Revenue
308 M
EPS
-0.53
Beta
1.021
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Procept Biorobotics Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Procept Biorobotics Corp data using free add-ons & libraries
Get Procept Biorobotics Corp Fundamental Data
Procept Biorobotics Corp Fundamental data includes:
- Net Revenue: 308 M
- EBITDA: -97 469 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-03
- EPS/Forecast: -0.3243
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Procept Biorobotics Corp News
New
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT). Su...
Procept BioRobotics price target lowered to $30 from $47 at Truist
Truist lowered the firm’s price target on Procept BioRobotics (PRCT) to $30 from $47 but keeps a Buy rating on the shares. The company’s Q4 missed estimates, though its Analyst Day laid out a case...
PROCEPT BioRobotics Investor Day: 2026 growth targets, higher ASPs, and profitability roadmap
PROCEPT BioRobotics logo Key Points 2026 financial targets: PROCEPT expects $390–$410 million in revenue (27%–33% growth), 60,000–64,000 procedures, a 65% gross margin and an adjusted EBITDA l...
A Look At PROCEPT BioRobotics (PRCT) Valuation After Q4 Revenue Miss And Softer 2026 Outlook
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. PROCEPT BioRobotics (PRCT) is back in focus after its Q4 2025 revenue miss, softer 2...
Get Procept Biorobotics Corp fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
